Your browser doesn't support javascript.
loading
First-in-human technique translation of oxygen-enhanced MRI to an MR Linac system in patients with head and neck cancer.
Dubec, Michael J; Buckley, David L; Berks, Michael; Clough, Abigael; Gaffney, John; Datta, Anubhav; McHugh, Damien J; Porta, Nuria; Little, Ross A; Cheung, Susan; Hague, Christina; Eccles, Cynthia L; Hoskin, Peter J; Bristow, Robert G; Matthews, Julian C; van Herk, Marcel; Choudhury, Ananya; Parker, Geoff J M; McPartlin, Andrew; O'Connor, James P B.
Afiliação
  • Dubec MJ; Division of Cancer Sciences, University of Manchester, Manchester, UK; Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK. Electronic address: Michael.Dubec@nhs.net.
  • Buckley DL; Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK; Biomedical Imaging, University of Leeds, Leeds, UK.
  • Berks M; Division of Cancer Sciences, University of Manchester, Manchester, UK.
  • Clough A; Radiotherapy, The Christie NHS Foundation Trust, Manchester, UK.
  • Gaffney J; Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Datta A; Division of Cancer Sciences, University of Manchester, Manchester, UK; Radiology, The Christie NHS Foundation Trust, Manchester, UK.
  • McHugh DJ; Division of Cancer Sciences, University of Manchester, Manchester, UK; Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK.
  • Porta N; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.
  • Little RA; Division of Cancer Sciences, University of Manchester, Manchester, UK.
  • Cheung S; Division of Cancer Sciences, University of Manchester, Manchester, UK.
  • Hague C; Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Eccles CL; Division of Cancer Sciences, University of Manchester, Manchester, UK; Radiotherapy, The Christie NHS Foundation Trust, Manchester, UK.
  • Hoskin PJ; Division of Cancer Sciences, University of Manchester, Manchester, UK; Department of Clinical Oncology, Mount Vernon Cancer Centre, Northwood, UK.
  • Bristow RG; Division of Cancer Sciences, University of Manchester, Manchester, UK; Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Matthews JC; Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK.
  • van Herk M; Division of Cancer Sciences, University of Manchester, Manchester, UK.
  • Choudhury A; Division of Cancer Sciences, University of Manchester, Manchester, UK; Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Parker GJM; Bioxydyn Ltd, Manchester, UK; Centre for Medical Image Computing, Department of Medical Physics and Biomedical Engineering, University College London, London, UK.
  • McPartlin A; Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Radiation Oncology, Princess Margaret Cancer Center, Toronto, Canada.
  • O'Connor JPB; Division of Cancer Sciences, University of Manchester, Manchester, UK; Radiology, The Christie NHS Foundation Trust, Manchester, UK; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
Radiother Oncol ; 183: 109592, 2023 06.
Article em En | MEDLINE | ID: mdl-36870608
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Oxigênio / Neoplasias de Cabeça e Pescoço Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Radiother Oncol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Oxigênio / Neoplasias de Cabeça e Pescoço Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Radiother Oncol Ano de publicação: 2023 Tipo de documento: Article